Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diffuse Intrinsic Pontine Glioma × Pharmacogenomic Variants × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, T-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Hodgkin Disease 2 Glioma 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Peritoneal Neoplasms 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Multiple Myeloma 1 Medulloblastoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Prolymphocytic, B-Cell 1

Interventions

Temozolomide 15 Radiotherapy 10 Bevacizumab 6 Irinotecan 5 Everolimus 5 Cyclophosphamide 5 ribociclib 4 Radiation 4 TIC10 compound 3 Re-Irradiation 3 Panobinostat 3 Etoposide 3 Dasatinib 3 pembrolizumab 2 nimotuzumab 2 abemaciclib 2 Vorinostat 2 Valproic Acid 2 Topotecan 2 Specimen Handling 2 Nivolumab 2 Mebendazole 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 GDC-0084 2 Erlotinib Hydrochloride 2 Diphtheria-Tetanus Vaccine 2 Cilengitide 2 Cetuximab 2 1-methyltryptophan 2 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01165333 2026-03-16

CILENT

Centre Oscar Lambret

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡